DGAM
CRL icon

Desjardins Global Asset Management’s Charles River Laboratories CRL Stock Holding History

Desjardins Global Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$8.98K Hold
38
– – ﹤0.01% 637
2023
Q3 		$7.45K Sell
38
-222
-85% -$45.6K ﹤0.01% 660
2023
Q2 		$54.7K Buy
260
+109
+72% +$21.7K 0.01% 531
2023
Q1 		$30K Buy
+151
New +$34.2K ﹤0.01% 550

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Desjardins Global Asset Management's CRL Position: Q4 2023 in Review

Desjardins Global Asset Management held its Charles River Laboratories (CRL) position steady in Q4 2023 at 38 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Desjardins Global Asset Management first reported a position in CRL in Q1 2023 and has held it in 4 quarters since. The position peaked at $54.7K in Q2 2023. 633 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Desjardins Global Asset Management held 38 shares of Charles River Laboratories worth $8.98K as of Q4 2023.
  • Desjardins Global Asset Management left its Charles River Laboratories share count unchanged in Q4 2023.
  • Charles River Laboratories made up ﹤0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #637 holding.
  • Desjardins Global Asset Management first reported a position in Charles River Laboratories in Q1 2023 and has held it in 4 quarters since.
  • Desjardins Global Asset Management's Charles River Laboratories position peaked at $54.7K in Q2 2023.
  • 633 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.